These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7917225)

  • 1. Effect of gamma-interferon on the synthesis of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro.
    Berge V; Johnson E; Nazir M
    APMIS; 1994 Jul; 102(7):554-8. PubMed ID: 7917225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads.
    Berge V; Johnson E; Høgåsen K
    APMIS; 1997 Jan; 105(1):17-24. PubMed ID: 9063496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 alpha, interleukin 6 and tumor necrosis factor alpha increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro.
    Berge V; Johnson E; Berge KE
    APMIS; 1996 Mar; 104(3):213-9. PubMed ID: 8611196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitronectin modulates the expression of complement components of the terminal pathway synthesized by human umbilical vein endothelial cells in vitro.
    Berge V; Berge KE; Johnson E
    APMIS; 1996; 104(7-8):523-30. PubMed ID: 8920805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Johnson E; Hetland G
    Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells.
    Tsuji S; Kaji K; Nagasawa S
    J Biochem; 1994 Oct; 116(4):794-800. PubMed ID: 7883753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.
    Brooimans RA; Hiemstra PS; van der Ark AA; Sim RB; van Es LA; Daha MR
    J Immunol; 1989 Mar; 142(6):2024-30. PubMed ID: 2522130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro.
    Johnson E; Hetland G
    Scand J Clin Lab Invest; 1988 May; 48(3):223-31. PubMed ID: 3287591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical vein endothelial cells synthesize S-protein (vitronectin) in vitro.
    Berge V; Johnson E; Høgåsen K; Hetland G
    Scand J Immunol; 1992 Jul; 36(1):119-23. PubMed ID: 1377399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system.
    Langeggen H; Pausa M; Johnson E; Casarsa C; Tedesco F
    Clin Exp Immunol; 2000 Jul; 121(1):69-76. PubMed ID: 10886241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts.
    Garred P; Hetland G; Mollnes TE; Stoervold G
    Scand J Immunol; 1990 Nov; 32(5):555-60. PubMed ID: 2270435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil extracellular traps can activate alternative complement pathways.
    Wang H; Wang C; Zhao MH; Chen M
    Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro biosynthesis of complement factor I by human endothelial cells.
    Julen N; Dauchel H; Lemercier C; Sim RB; Fontaine M; Ripoche J
    Eur J Immunol; 1992 Jan; 22(1):213-7. PubMed ID: 1530917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosanoids are regulatory molecules in gamma-interferon-induced endothelial antigenicity and adherence for leucocytes.
    Leszczynski D; Häyry P
    FEBS Lett; 1989 Jan; 242(2):383-6. PubMed ID: 2492473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression.
    Dalmasso AP; Benson BA; Johnson JS; Lancto C; Abrahamsen MS
    J Immunol; 2000 Apr; 164(7):3764-73. PubMed ID: 10725736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture.
    Ripoche J; Mitchell JA; Erdei A; Madin C; Moffatt B; Mokoena T; Gordon S; Sim RB
    J Exp Med; 1988 Nov; 168(5):1917-22. PubMed ID: 2972796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).
    Mollnes TE; Redl H; Høgåsen K; Bengtsson A; Garred P; Speilberg L; Lea T; Oppermann M; Götze O; Schlag G
    Clin Exp Immunol; 1993 Feb; 91(2):295-300. PubMed ID: 7679061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of complement by alveolar macrophages from patients with sarcoidosis.
    Pettersen HB; Johnson E; Mollnes TE; Garred P; Hetland G; Osen SS
    Scand J Immunol; 1990 Jan; 31(1):15-23. PubMed ID: 1689072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assessment of mouse complement pathway activities and quantification of C3b/C3c/iC3b in an experimental model of mouse renal ischaemia/reperfusion injury.
    Kotimaa JP; van Werkhoven MB; O'Flynn J; Klar-Mohamad N; van Groningen J; Schilders G; Rutjes H; Daha MR; Seelen MA; van Kooten C
    J Immunol Methods; 2015 Apr; 419():25-34. PubMed ID: 25733354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.